News for Panaxia Labs Israel Ltd (PNAX.TA)

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) provided an update on its transaction with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., part of the Panaxia Labs Israel, Ltd. group of companies, (collectively,

/PRNewswire/ -- Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia...

Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the license allows...

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1).

- Net Israeli revenues in 2021 increased 38% to 83.6 million. - Initial revenues from medical cannabis oils export from Israel, which began at the end of 2020,...

/PRNewswire/ -- Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company which develops, manufactures and markets progressive medical...

Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official auth...

TEL AVIV, Israel, Jan. 3, 2022 /PRNewswire/ --  Panaxia Global, the controlling owner of   Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that

Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) ...

/PRNewswire/ -- Panaxia Labs Israel Ltd. (

Below is a recap of the main news related to the cannabis industry and markets for the week of August 30, 2021.

In one of the craziest weeks in the history of public markets, cannabis stocks and ETFs delivered mixed performances. Over the last five trading da...